0 Kommentare
0 Anteile
172 Ansichten
0 Vorschau
Search
Entdecken Sie neue Leute, neue Verbindungen zu schaffen und neue Freundschaften
-
Please log in to like, share and comment!
-
Fermentation Monitoring Sensors Market Expands with Rising Demand for Precision Bioprocessing SolutionsFermentation Monitoring Sensors Market, valued at a robust USD 1.05 billion in 2025, is on a trajectory of significant expansion, projected to reach USD 2.01 billion by 2034. This growth, representing a compound annual growth rate (CAGR) of 7.8%, is detailed in a comprehensive new report published by Semiconductor Insight. The study highlights the critical role of these advanced sensors...0 Kommentare 0 Anteile 318 Ansichten 0 Vorschau
-
What Are the Trends in Continuous Bioprocessing Consumables Market for Biopharma?Continuous Bioprocessing Consumables Market Summary: According to the latest report published by Data Bridge Market Research, the Continuous Bioprocessing Consumables Market CAGR Value The global continuous bioprocessing consumables market size was valued at USD 656.88 million in 2025 and is expected to reach USD 1,927.06 million by 2033, at a CAGR of 14.40% during the forecast...0 Kommentare 0 Anteile 1KB Ansichten 0 Vorschau
-
Global Microbial Fermentation APIs Market Growing at 1.5% CAGR Through 2032According to a new report from Intel Market Research, the global Microbial Fermentation APIs market was valued at USD 27.57 billion in 2024 and is projected to reach USD 30.56 billion by 2032, exhibiting a steady CAGR of 1.5% during the forecast period (2025–2032). This growth is driven by the increasing demand for antibiotics, amino acids, and vitamins, particularly in emerging economies...0 Kommentare 0 Anteile 10 Ansichten 0 Vorschau
-
United States Sterile Fill-Finish for Cell and Gene Therapies Market Growing at 8.9%According to a new report from Intel Market Research, the United States Sterile Fill-Finish for Cell and Gene Therapies Market was valued at USD 0.54 billion in 2025 and is projected to reach USD 1.04 billion by 2034, growing at a robust CAGR of 8.9% during the forecast period (2025–2034). This expansion is driven by accelerating investments in cell‑and‑gene therapy pipelines, supportive...0 Kommentare 0 Anteile 237 Ansichten 0 Vorschau